Abstract:OBJECTIVE:To assess the estrogen and progestin's effect on protein expression of metastasis repression gene nm23-H1 via regulation of phosphorylation signaling in epithelial ovarian cancer cell line ES-2.METHODS:Ovarian clear cell adenocarcinom cell line ES-2 was treated by different doses of 17beta-estradiol (estrogen), medroxyprogestogen (progestin) and dimethyl sulfoxide (control group), and then the following experiments were conducted. (1) Change of the cell migration capacity after treatment with estrogen and progestin for 24 and 48 hours was measured by in vitro wound healing assay. (2) Transwell experiments were used to detect the ability of cell invasion, which was also used to inhibit the phosphorylation of protein kinase B (AKT) pathway with estrogen and progestin. (3) Change of nm23-H1, AKT and phosphorylated protein kinase B (pAKT) protein level of ES-2 cells after treated with estrogen and progestin was detected by western blot. (4) Cells were transfected with the small interfering RNA (siRNA) expression vector targeting AKT. The efficiency of cells transfected was calculated according to the number of cells with green fluorescent produced by cells transfected. Change of nm23-H1 expression was assessed.RESULTS:ES-2 cells treated with estrogen, progestin or vehicle all migrated into the wound surface after 24 and 48 hours. The migration of the cells treated with estrogen was (1.39 +/- 0.08) mm, significantly elevated (P = 0.029), and that of the cells treated with progestin was (1.96 +/- 0.07) mm, significantly decreased compared with cells treated with vehicle (P = 0.014). The cells were cultured in transwell after 24 hours. The invasion of the cells treated with estrogen was 119 +/- 13, significantly elevated (P = 0.015), and that of the cells treated with progestin was 78 +/- 8, significantly decreased compared with cells treated with vehicle (P = 0.006). Western blot results showed that 17beta-estradiol decreased nm23-H1 expression, and both effects were dose and time dependent (P = 0.020, P = 0.001). Progestin increased nm23-H1 expression in ES-2 cells, and both effects were dose and time dependent (P = 0.003, P = 0.002). 17beta-Estradiol elevated the expression of pAKT, which was also dose and time dependent (P = 0.001, P = 0.007), while progestin repressed pAKT expression which was also dose and time dependent (P = 0.012, P = 0.039). When cells were transfected with the siRNA expression vector targeting AKT, the effects of estrogen and progestin on nm23-H1 expression were both attenuated.CONCLUSIONS:Estrogen downregulates the expression of nm23-H1 via activation of the phosphorylation signaling, thus participated in the regulation of invasion and metastasis of epithelial ovarian cancer cells. Progestin upregulates the expression of nm23-H1, and might repress invasion and metastasis of tumor cells.

Regulation effects of estrogen and progestogen on the expression of KLK4 mRNA and protein in human endometrial carcinoma cell line KLE

Kallikrein 4 Overexpression in Endometrial Carcinoma and Upregulation by Estrogen Via Mitogen-Activated Protein Kinase Signal Pathway

The Effect of Progesterone and Tamoxifen on Cell Proliferation and the Expression of Estrogen Receptor Related Receptor of Endometrial Carcinoma

Function of Estrogen Receptor Isoforms Α and Β in Endometrial Carcinoma Cells

Effect of Extra-expression of Estrogen Receptor in Restoration of Regulation of Estrogen on Notch Signaling Pathway in Endometrial Cancer Cells

Crosstalk Between Estrogen Receptor and Mitogen-Activated Protein Kinase Signaling in the Development and Progression of Endometrial Cancer

Kallikrein-Related Peptidase 4 Promotes Proliferation, Migration, Invasion, and Pro-Angiogenesis of Endometrial Stromal Cells via Regulation of Brain-Derived Neurotrophic Factor Production in Endometriosis

Over-expression EGFR reduced sensitivity of human endometrial carcinoma cells to progesterone

Expression of human kallikrein 4 in endometrial carcinoma and its influence on prognosis

Multifactor Regulation on Expressions of MMP-9 and TIMP-1 in Endometrial Stromal Cells

[Effect of Estrogen and Progesterone on the Expression of VEGF Mrna in Epithelial Ovarian Cancer Cell Line].

[Regulatory Effect of 17Beta-Estradiol on Expression of Orphan Nuclear Receptor ERRalpha in Endometrial Carcinoma Cell Lines].

Effect of expression of intermediate-conductance Ca~(2+) -activated K~+ channels on proliferation,cell cycle,and apoptosis of human endometrial carcinoma

Downregulation of PDCD4 Induced by Progesterone is Mediated by the PI3K/AKT Signaling Pathway in Human Endometrial Cancer Cells.

Expression of Estrogen and Progesterone Receptor Subtypes in Human Endometrial Carcinoma Tissues

Study on the regulatory effect of estrogen receptor α on the invasion of endometrial carcinoma

[Regulation of Orphan Receptor ERR Alpha by Estrogen and Progesterone in Endometrial Carcinoma Cell Line].

Impact of estradiol in inducing endometrial cancer using RL95-2

[Influence of Estrogen and Progestin on Nm23-H1 Expression in Epithelial Ovarian Cancer Cell Lines Via Activation of Phosphorylation Signaling].

[In Vitro Study of the Effects of Estrogen Receptor Beta Expression on the Biological Behavior of a Human Breast Cancer Cell Line].

Modulation and function of estrogen receptor isoforms alpha and beta in endometrial carcinoma cells]